High b Value (2,000 s/mm2) Diffusion-Weighted Magnetic Resonance Imaging in Prostate Cancer at 3 Tesla: Comparison with 1,000 s/mm2 for Tumor Conspicuity and Discrimination of Aggressiveness

Objective The objective of our study was to investigate tumor conspicuity and the discrimination potential for tumor aggressiveness on diffusion-weighted magnetic resonance imaging (DW-MRI) with high b value at 3-T. Materials and Methods The institutional review board approved this study and waived the requirement for informed consent. A total of 50 patients with prostate cancer (69 cancer foci; 48 in the PZ, 20 in the TZ, and one in whole prostate) who underwent multiparametric prostate MRI including DW-MRI (b values: 0, 1000 s/mm2 and 0, 2000 s/mm2) on a 3-T system were included. Lesion conspicuity score (LCS) using visual assessment (1 = invisible for surrounding normal site; 2 = slightly high intensity; 3 = moderately high; and 4 = very high) and tumor-normal signal intensity ratio (TNR) were assessed, and apparent diffusion coefficient (ADC, ×10−3 mm2/s) of the tumor regions and normal regions were measured. Results Mean LCS and TNR at 0, 2000 s/mm2 was significantly higher than those at 0, 1000 s/mm2 (p<0.001 for both). In addition, ADC at both 0, 1000 and 0, 2000 s/mm2 was found to distinguish intermediate or high risk cancer with Gleason score ≥7 from low risk cancer with Gleason score ≤6 (p<0.001 for both). Furthermore, ADC of tumor regions correlated with Gleason score at both 0, 1000 s/mm2 (ρ = −0.602; p<0.001) and 0, 2000 s/mm2 (ρ = −0.645; p<0.001). Conclusions For tumor conspicuity and characterization of prostate cancer on DW-MRI of 3-T MRI, b = 0, 2000 s/mm2 is more useful than b = 0, 1000 s/mm2.

[1]  P. Grenier,et al.  MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. , 1986, Radiology.

[2]  D. Le Bihan,et al.  Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. , 1988, Radiology.

[3]  N. Dubrawsky Cancer statistics , 1989, CA: a cancer journal for clinicians.

[4]  W. Fair,et al.  Correlation between Gleason score of needle biopsy and radical prostatectomy specimen: accuracy and clinical implications. , 1997, The Journal of urology.

[5]  J Kurhanewicz,et al.  Localizing prostate cancer in the presence of postbiopsy changes on MR images: role of proton MR spectroscopic imaging. , 1998, Radiology.

[6]  J. Petrella,et al.  Use of MR exponential diffusion-weighted images to eradicate T2 "shine-through" effect. , 1999, AJR. American journal of roentgenology.

[7]  A. Elster,et al.  Acute cerebral infarction: quantification of spin-density and T2 shine-through phenomena on diffusion-weighted MR images. , 1999, Radiology.

[8]  P. Babb,et al.  Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part II: individual countries , 2002, BJU international.

[9]  P. Babb,et al.  Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part I: international comparisons , 2002, BJU international.

[10]  L. Egevad,et al.  The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma , 2005, The American journal of surgical pathology.

[11]  Y. Jo,et al.  Transperineal extended biopsy improves the clinically significant prostate cancer detection rate: A comparative study of 6 and 12 biopsy cores , 2006, International journal of urology : official journal of the Japanese Urological Association.

[12]  B. K. Park,et al.  Diffusion-Weighted Imaging of the Prostate at 3 T for Differentiation of Malignant and Benign Tissue in Transition and Peripheral Zones: Preliminary Results , 2007, Journal of computer assisted tomography.

[13]  Masao Fukunaga,et al.  Prostate cancer: relationships between postbiopsy hemorrhage and tumor detectability at MR diagnosis. , 2008, Radiology.

[14]  John Kurhanewicz,et al.  Dynamic contrast-enhanced MRI and MR diffusion imaging to distinguish between glandular and stromal prostatic tissues. , 2008, Magnetic resonance imaging.

[15]  M. Soloway,et al.  Trends in Gleason score: concordance between biopsy and prostatectomy over 15 years. , 2008, Urology.

[16]  S. Fosså,et al.  Concordance between Gleason scores of needle biopsies and radical prostatectomy specimens: a population‐based study , 2009, BJU international.

[17]  C. Kim,et al.  Diffusion-weighted MRI at 3 T for the evaluation of prostate cancer. , 2010, AJR. American journal of roentgenology.

[18]  L. Kiemeney,et al.  The length of positive surgical margins correlates with biochemical recurrence after radical prostatectomy , 2010, Histopathology.

[19]  Chronic Disease Division Cancer facts and figures , 2010 .

[20]  Aytekin Oto,et al.  Prostate cancer: differentiation of central gland cancer from benign prostatic hyperplasia by using diffusion-weighted and dynamic contrast-enhanced MR imaging. , 2010, Radiology.

[21]  T. Metens,et al.  What is the optimal b value in diffusion-weighted MR imaging to depict prostate cancer at 3T? , 2012, European Radiology.

[22]  Baris Turkbey,et al.  Is apparent diffusion coefficient associated with clinical risk scores for prostate cancers that are visible on 3-T MR images? , 2011, Radiology.

[23]  Thomas Hambrock,et al.  Prostate cancer: multiparametric MR imaging for detection, localization, and staging. , 2011, Radiology.

[24]  T. Sone,et al.  Prostate cancer detection in patients with total serum prostate-specific antigen levels of 4-10 ng/mL: diagnostic efficacy of diffusion-weighted imaging, dynamic contrast-enhanced MRI, and T2-weighted imaging. , 2011, AJR. American journal of roentgenology.

[25]  A. Oto,et al.  Diffusion-weighted and dynamic contrast-enhanced MRI of prostate cancer: correlation of quantitative MR parameters with Gleason score and tumor angiogenesis. , 2011, AJR. American journal of roentgenology.

[26]  S. Verma,et al.  Assessment of aggressiveness of prostate cancer: correlation of apparent diffusion coefficient with histologic grade after radical prostatectomy. , 2011, AJR. American journal of roentgenology.

[27]  J. Fütterer,et al.  ESUR prostate MR guidelines 2012 , 2012, European Radiology.

[28]  G. Johnson,et al.  Prostate cancer: feasibility and preliminary experience of a diffusional kurtosis model for detection and assessment of aggressiveness of peripheral zone cancer. , 2012, Radiology.

[29]  Takeshi Yoshikawa,et al.  Clinical utility of apparent diffusion coefficient values obtained using high b‐value when diagnosing prostate cancer using 3 tesla MRI: Comparison between ultra‐high b‐value (2000 s/mm2) and standard high b‐value (1000 s/mm2) , 2012, Journal of magnetic resonance imaging : JMRI.

[30]  Beom Jin Park,et al.  Detectability of low and intermediate or high risk prostate cancer with combined T2-weighted and diffusion-weighted MRI , 2012, European Radiology.

[31]  A. Jemal,et al.  Cancer statistics, 2012 , 2012, CA: a cancer journal for clinicians.

[32]  Masaaki Kawahara,et al.  Diagnostic accuracy of ultra-high-b-value 3.0-T diffusion-weighted MR imaging for detection of prostate cancer. , 2012, Clinical imaging.

[33]  D. Margolis,et al.  MR spectroscopic imaging and diffusion‐weighted imaging of prostate cancer with Gleason scores , 2012, Journal of magnetic resonance imaging : JMRI.

[34]  M. Moche,et al.  Diagnostic value of ADC in patients with prostate cancer: influence of the choice of b values , 2012, European Radiology.

[35]  F. De Keyzer,et al.  Genitourinary applications of diffusion-weighted MR imaging in the pelvis. , 2012, Radiology.

[36]  P. P. Iu,et al.  ESUR prostate MR guidelines. , 2013, European radiology.

[37]  B. K. Park,et al.  Diffusion-Weighted Magnetic Resonance Imaging for the Evaluation of Prostate Cancer: Optimal B Value at 3T , 2012, Korean journal of radiology.

[38]  J. Babb,et al.  Diffusion‐weighted imaging of the prostate: Comparison of b1000 and b2000 image sets for index lesion detection , 2013, Journal of magnetic resonance imaging : JMRI.

[39]  Makoto Obara,et al.  Ultra‐high b‐value diffusion‐weighted MRI for the detection of prostate cancer with 3‐T MRI , 2013, Journal of magnetic resonance imaging : JMRI.

[40]  Katsuyoshi Ito,et al.  Diffusion‐weighted MRI and its role in prostate cancer , 2014, NMR in biomedicine.

[41]  U. G. Dailey Cancer,Facts and Figures about. , 2022, Journal of the National Medical Association.